PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.
A state-of-the-art cancer centre is scheduled to open within Holmesglen Private Hospital in September this year, offering the latest in advanced radiation therapy.
Victorian women who have undergone breast implant or breast reconstructive procedures are being encouraged to watch for early symptoms of a rare form of cancer.
The update means the resource now includes latest national data on how cancer diagnosis and excess death rates vary by geographical area across Australia.
Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation.
A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden.
A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants.
An international team of researchers, led by The University of Melbourne, has found two new mammogram-based measures for breast cancer risk.
An international study has uncovered new evidence of the positive role of androgens in breast cancer treatment.
GE Healthcare and GenesisCare have partnered to tackle the globe's greatest health burdens: cancer and cardiovascular disease.
The secret pathway used by some aggressive breast cancers to avoid detection has been uncovered by researchers at Macquarie University.
The National Strategic Action Plan for Blood Cancer aims to unite Australia towards the goal of zero lives lost to blood cancer by 2035.
Melbourne identical twins have joined a major new study investigating why only one twin in a pair develops breast cancer, or if both twins are diagnosed, why one twin does so earlier.
Daily coffee consumption has been associated with improved survival in patients with metastatic colorectal cancer, according to a study led by Dana-Farber Cancer Institute.
A new report has revealed the unseen burden of non-melanoma skin cancer in Australia.